Deals of the week: Pfizer management updates thoughts on split (Pink Sheet - Informa) - Apr 1, 2013 - In March 2013, the companies launched Abilify Maintena (aripiprazole depot) which is set to lose patent protection in 2015; Lu AE58054 is expected to begin three phase III trials later this year involving 2,500 patients for Alzheimer's disease.
Anticipated new P3 trial • Launch • Patent • Alzheimer's Disease • Schizophrenia
|
|
A subscription to The Pink Sheet is required to access this article
|